Immunotherapy-related adverse effects on 18 F-FDG PET/CT imaging

F-Fluorodeoxyglucose positron emission tomography/CT imaging plays a key role in oncological imaging including in staging, radiotherapy planning, treatment response and recurrence assessment. Immunotherapies represent a major advance in cancer therapy for a number of tumours with resulting survival...

Full description

Saved in:
Bibliographic Details
Published in:British journal of radiology 2020-02, p.20190832
Main Authors: Gandy, Nemi, Arshad, Mubarik A, Wallitt, Kathryn L, Dubash, Suraiya, Khan, Sameer, Barwick, Tara D
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:F-Fluorodeoxyglucose positron emission tomography/CT imaging plays a key role in oncological imaging including in staging, radiotherapy planning, treatment response and recurrence assessment. Immunotherapies represent a major advance in cancer therapy for a number of tumours with resulting survival benefit. However, a wide range of immune related adverse events (irAEs), some of which can be apparent on imaging, have been reported. These involve many organ systems but particularly endocrine, cutaneous and gastrointestinal systems. Early detection of irAEs is essential to aid diagnosis and management of patients and to reduce associated morbidity. In addition, it is important to not mistake treatment related effects for disease.This pictorial review aims to identify common irAEs and changes seen on F-fluorodeoxyglucose positron emission tomography/CT.
ISSN:1748-880X